Skip to content
10-K

Annual Report

Milestone Pharmaceuticals Inc. MIST

0001104659-26-032415

← back to feed
Filed
Mar 20, 2026 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2025 · Mar 20, 2026 117.67M sh
Capex FY 2025 · Dec 31, 2025 $302K
Capex FY 2025 · Dec 31, 2024 $33K
Operating Cash Flow FY 2025 · Dec 31, 2025 −$49.04M
Operating Cash Flow FY 2025 · Dec 31, 2024 −$28.85M
Long Term Debt FY 2025 · Dec 31, 2025 $57.19M
Long Term Debt FY 2025 · Dec 31, 2024 $53.35M
Short Term Investments FY 2025 · Dec 31, 2025 $32.91M
Short Term Investments FY 2025 · Dec 31, 2024 $44.38M
Cash And Equivalents FY 2025 · Dec 31, 2025 $73.05M
Cash And Equivalents FY 2025 · Dec 31, 2024 $25.31M
Stockholders Equity FY 2025 · Dec 31, 2025 $41.77M
Stockholders Equity FY 2025 · Dec 31, 2024 $13.15M
Stockholders Equity FY 2025 · Dec 31, 2023 $16.77M
Current Liabilities FY 2025 · Dec 31, 2025 $13.98M
Current Liabilities FY 2025 · Dec 31, 2024 $8.13M
Total Liabilities FY 2025 · Dec 31, 2025 $71.79M
Total Liabilities FY 2025 · Dec 31, 2024 $62.35M
Current Assets FY 2025 · Dec 31, 2025 $111.92M
Current Assets FY 2025 · Dec 31, 2024 $73.93M
Total Assets FY 2025 · Dec 31, 2025 $113.56M
Total Assets FY 2025 · Dec 31, 2024 $75.5M
Eps Diluted FY 2025 · Dec 31, 2025 −$0.75
Eps Diluted FY 2025 · Dec 31, 2024 −$0.67
Eps Basic FY 2025 · Dec 31, 2025 −$0.75
Eps Basic FY 2025 · Dec 31, 2024 −$0.67
Sga Expense FY 2025 · Dec 31, 2025 $17.27M
Sga Expense FY 2025 · Dec 31, 2024 $16.74M
Rd Expense FY 2025 · Dec 31, 2025 $18.11M
Rd Expense FY 2025 · Dec 31, 2024 $14.36M
Net Income FY 2025 · Dec 31, 2025 −$63.06M
Net Income FY 2025 · Dec 31, 2024 −$41.52M
Operating Income FY 2025 · Dec 31, 2025 −$62.14M
Operating Income FY 2025 · Dec 31, 2024 −$42.1M
Stock Issued FY 2025 · Jul 11, 2025 31.5M sh